PreComb develops technologies to optimally adapt the therapies to each patient for difficult-to-treat cancers.
PreComb's investors include HTGF (High-Tech Gruenderfonds), SICTIC, LongeVC, Kinled Holding, FiveT Capital AG.
PreComb is headquartered in Hombrechtikon, Switzerland.
PreComb develops technologies to optimally adapt the therapies to each patient for difficult-to-treat cancers.
PreComb is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PreComb — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/precomb. Accessed October 29, 2026.
VCBacked. (2024). PreComb — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/precomb
{{cite web |title=PreComb — Funding & Investors |url=https://www.vcbacked.co/company/precomb |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated